Vertaling van "economically " (Nederlands → Frans) :

Auteurs: Philippe Beutels (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Wetenschappelijk Instituut Volksgezondheid), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Christelijke Mutualiteit), Michael Callens (Christelijke Mutualiteit), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).
Auteurs : Philippe Beutels (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Institut Scientifique de Santé Publique), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Mutualité chrétienne), Michael Callens (Mutualité chrétienne), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).

We do, of course, have economic responsibilities – to our customers, associates and shareholders. When we operate in a way that is respectful of human rights, socially equitable and environmentally sustainable, we can better meet our economic responsibilities.
Nous assumons bien évidemment nos responsabilités commerciales, à l’égard de nos clients, de nos collaborateurs et de tous ceux qui sont concernés par nos activités ; mais nous pensons mieux les assumer en adoptant un comportement respectueux des droits humains, de l’environnement et socialement équitable.

Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke [see comments].
Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke.

36. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
36. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ et al. The clinical effectiveness and cost-effectiveness of Bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.

controlled trial without randomization double blind double blind randomised placebo controlled trial economic evaluation evaluation guidelines
case series cross-sectional study controlled trial without randomization double blind double blind randomised placebo controlled trial economic evaluation evaluation guidelines

Health Care Economics and Organizations; Musculoskeletal System; Nervous System Diseases; Rehabilitation
Health Care Economics and Organizations Langue; Musculoskeletal System; Nervous System Diseases; Rehabilitation

58. Health Policy & Economic Research Unit.
57. Health Policy & Economic Research Unit.

Malaria kills a child under age five every 30 seconds in Africa Only 10% of R&D funds are used for research into 90% of the world’s health problems The NITD was granted USD 20 million in 2006 by the Wellcome Trust, the Singapore Economic Development Board and Medicines for Malaria Venture to initiate joint research on malaria Leprosy has dropped by over 90% since 1985 Deliveries for Coartem have climbed from four million treatments in 2004 to over 60 million in 2006
En Afrique, la malaria tue un enfant de moins de cinq ans toutes les 30 secondes Seuls 10% des fonds consacrés à la recherche sont investis dans les maladies qui représentent 90% des problèmes de santé dans le monde En 2006, l’Institut Novartis pour les maladies tropicales a obtenu du Wellcome Trust, du Singapore Economic Development Board et de Medicines for Malaria Venture USD 20 millions pour initier un programme commun de recherche sur la malaria Depuis 1985, la lèpre a diminué de plus de 90% Entre 2004 et 2006, les livraisons de Coartem sont passées de 4 millions à plus de 60 millions de traitements

‘We do everything we can to operate in a manner that is sustainable: economically, socially, and environmentally – in the best interest of long-term success for our enterprise’.
« Nous entreprenons tous les efforts nécessaires pour opérer dans une optique de développement durable, tant sur le plan économique et social que de l’environnement, afin d’assurer la réussite à long terme de notre entreprise».

Externe Validatoren: Ann-Lise Guisset (WHO), Irene Papanicolas (London School of Economics and Political Science), Niek Klazinga (Academisch Medisch Centrum – Universiteit van Amsterdam)
Validateurs externes : Ann-Lise Guisset (WHO), Irene Papanicolas (London School of Economics and Political Science), Niek Klazinga (Academisch Medisch Centrum – Universiteit van Amsterdam)